Address
1941 Stryker Way
Portage, MI 49002
United States of America (the)
Phone
269 385 2600
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
53000
First IPO Date
March 17, 1980
| Name | Title | Pay | Year Born |
| Kevin A. Lobo | Chairman & CEO | 4.72M | 1965 |
| Robert S. Fletcher | Vice President & Chief Legal Officer | 895,895 | 1971 |
| Viju S. Menon | Group President of Global Quality & Operations | 1.42M | 1968 |
| Preston Wells | Vice President & Chief Financial Officer | 1.49M | 1977 |
| J. Andrew Pierce | Group President of MedSurg & Neurotechnology | 1.73M | 1974 |
| Spencer S. Stiles | President & COO | 1.74M | 1977 |
| Dragana Bunjevac | President of Eastern Europe, Middle East & Africa | 0 | N/A |
| Jason Beach | VP and Group CFO of MedSurg & Neurotechnology | 0 | N/A |
| Debra S. King | VP and Chief Digital & Information Officer | 0 | 1972 |
| Nick Mead | Vice President of Investor Relations | 0 | N/A |
| William E. Berry Jr. | Vice President & Chief Accounting Officer | 0 | 1966 |
| Robert C. Cohen | Chief Technology Officer and Vice President of Global R&D - Joint Replacement | 0 | N/A |
| Dana S. McMahon | Vice President & Chief Compliance Officer | 0 | N/A |
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.